Moreover, the preferential expression of the hypoxic and castration resistance gene set within the Cases group of the Porto cohort and the identification of ZNF560 in the CPC-Gene cohort demonstrate there is a chronic hypoxia mechanism involved in prostate cancer progression. The gene discussed is ZNF560; the disease is Familial prostate cancer.